organization

CELLTECH R&D LIMITED

  • project . 2015 - 2018
    Funder: EC Project Code: 642836
    Overall Budget: 3,685,070 EURFunder Contribution: 3,685,070 EUR
    Open Access mandate for Publications
    Partners: University of Kent, University of Greifswald, CELLTECH R&D LIMITED, UCB Pharma (Belgium), DSM, HU, Stockholm University, UNIVERSITAIR MEDISCH CENTRUM GRONINGEN, NOVOZYMES A/S, INRAE

    The market for recombinant proteins, including biopharmaceuticals, industrial enzymes and membrane proteins, is estimated to be about 78 billion Euro and rising. A high proportion of the target proteins are produced in bacteria, where secretion out of the cytoplasm is a...

  • project . 2016 - 2020
    Funder: EC Project Code: 675179
    Overall Budget: 3,342,320 EURFunder Contribution: 3,342,320 EUR
    Open Access mandate for Publications
    Partners: CNRS, WCAIR, ASTRAZENECA AB, UNISI, Taros Chemicals, University of Leeds, LDC, CELLTECH R&D LIMITED, UCB Pharma (Belgium), TU/e...

    The goal of the TASPPI European Training Network (ETN) is the establishment of a highly interdisciplinary research and educational training platform for early stage scientists in the Chemical Life Sciences to overcome the inherent boundaries between academia and industr...

  • project . 2014 - 2016
    Funder: EC Project Code: 605467
    Partners: ATEKNEA SOLUTIONS HUNGARY KFT, TRC, MEMMERT GMBH + CO.KG, PROMAUT, BUNTING MAGNETICS EUROPE LIMITED, NTRAM GENERAL S.A., CELLTECH R&D LIMITED, STEMMER IMAGING LTD, GOUDSMIT MAGNETIC SYSTEMS, Image Solutions (UK) Ltd...
  • project . 2019 - 2022
    Funder: EC Project Code: 813979
    Overall Budget: 4,087,420 EURFunder Contribution: 4,087,420 EUR
    Open Access mandate for Publications and Research Data
    Partners: University of Kent, ACIB GMBH, HU, BOEHRINGER INGELHEIM RCV GMBH & CO KG, LONZA AG, UCB Pharma (Belgium), University of Oulu, CELLTECH R&D LIMITED, AB Enzymes, UMG...

    The ‘SECRETERS’ partnership aims to bring about a step change in the production of recombinant proteins, particularly Biotherapeutics and Industrial Enzymes. Both are critical products for the EU biotechnology sector, with combined markets in excess of $140 billion p.a....

  • project . 2011 - 2014
    Funder: EC Project Code: 279143
    Open Access mandate for Publications Special Clause 39
    Partners: UOXF, UMIL, THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE, Imperial, HELSINGIN YLIOPISTO, NUS, University of Oulu, DEVKI DEVI FOUNDATION SOCIETY, NCGM, UNIVERSITY OF KELANIYA...
Powered by OpenAIRE Research Graph
Any information missing or wrong?Report an Issue